It is described as a "blue-violet liquid with specific odor, packed in orange glass bottles per 20ml and corked tightly by a rubber plug clutched by aluminum caps.
Phase 2A of clinical trials revealed a good tolerance of the drug, a certain direction of adverse events, which constituted an insignificant percentage of the number of observations.
The scientific supervisor from the beginning of the study and until the end of his life was the head of Infectious Diseases department of Yerevan State Medical University, Ph.D. Levon Mkhitaryan (d. 2009).
General management was entrusted to Prof. Emil Gabrielyan (d. 2010) – Director of the Republican Pharmacological Agency, who was a Minister of Health of the Armenian SSR in the past.
The reconstructed building was renamed into the “Armenicum Medical Center”, which to this day is engaged in the treatment of HIV infection and works on government orders.